Oncology patent intelligence

US 8435575

Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy

Aphios Corporation · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8426432

Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

UNIVERSITY OF CONNECTICUT · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8420885

Determining the capability of a test compound to affect solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8420665

Anti-cancer compounds

Northwestern University · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8415097

Tumor suppressor gene, p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8415294

Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth

THE ARIZONA BOARD OF REGENTS · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8410292

Epoxy-guaiane derivatives and treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8409566

Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

Northwest Biotherapeutics, Inc. · Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8404810

Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma

Five Prime Therapeutics, Inc. · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8404650

Methods of treating cancer with doxazolidine and prodrugs thereof

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8399428

Nucleosides with antiviral and anticancer activity

Regents of the University of Minnesota · Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8394411

Papillomavirus pseudoviruses for detection and therapy of tumors

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8394377

Methods for treating cancer using combination therapy

The Regents of the University of Colorado · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8388963

Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8377637

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8377450

Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer

United Cancer Research Institute · Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2013014107

SÉMULOPARINE POUR L'AMÉLIORATION DE LA SURVIE DE PATIENTS ATTEINTS D'UN CANCER

AVENTIS PHARMA SA [FR] · Granted Thu Jan 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8361710

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8349568

Method of diagnosing poor survival prognosis colon cancer using let-7g

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8343725

Method of diagnosing poor survival prognosis colon cancer using miR-10a

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338104

Method of diagnosing poor survival prognosis colon cancer using miR-103-2

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338102

Method of diagnosing poor survival prognosis colon cancer using miR-181b

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338103

Method of diagnosing poor survival prognosis colon cancer using miR-106a

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338105

Method of diagnosing poor survival prognosis colon cancer using miR-203

The United States of America as represented by the Secretary of the Department of Health and Human Services, National Institute of Health, Office of Technology Tansfer · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8338106

Method of diagnosing poor survival prognosis colon cancer using miR-29a

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329181

Methods for treating B-cell lymphoma by administering an anti-CD20 antibody

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8328785

Use of nanoparticles in the photodynamic treatment of tumors

The Board of Regents of the University of Texas System · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8329636

Carcinoma diagnosis and treatment, based on ODC1 genotype

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8323906

Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

The Board of Regents of the University of Texas System · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8323706

Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2012301425

NOVEL ANTITUMORAL USE OF CABAZITAXEL

GUPTA SUNIL [US] · Granted Thu Nov 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8304526

Antitumor effect of mutant Bik

The Board of Regents of the University of Texas System · Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8299033

Iodo-hexose compounds useful to treat cancer

The Board of Regents of the University of Texas System · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8299040

Methods for treating cancer targeting transglutaminase

The Board of Regents of the University of Texas System · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293240

Method of treating drug-resistant cancer

The Regents of the University of Colorado · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288342

Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

TEVA WOMEN'S HEALTH, INC. · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8278348

Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8273797

Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8273724

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8268786

Anti-cancer tocotrienol analogues and associated methods

First Tech International Limited · Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263085

Gammaretrovirus associated with cancer

The Regents of the University of California · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263759

Sets of probes and primers for the diagnosis of select cancers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

FR 2972192

COMPOSITION PHARMACEUTIQUE DESTINEE A LA PREVENTION OU AU TRAITEMENT DES CANCERS

BIOCODEX [FR] · Granted Fri Sep 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Sep 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258278

Methods and compositions for the treatment and prevention of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258263

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

The Regents of the University of California · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2491925

Antitumorigene Kombinaton, die Cabazitaxel und Cisplatin umfasst

AVENTIS PHARMA SA [FR] · Granted Wed Aug 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Aug 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252545

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252267

DKKL-1 splice product modulators for cancer diagnosis and therapy

Sagres Discovery, Inc. · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)